|
  
- 积分
- 635
- 威望
- 635
- 包包
- 192
|
本帖最后由 flydayzhu 于 2010-8-28 16:37 编辑
3 t* l# Z7 M t6 O! r# W
0 |4 }0 F; M: Q, s8 e麻烦大家了,最好是能够提供杂志版的,看着相对舒服点,谢谢~
; G9 [6 H) {) u' @( d1 G* u7 e3 ~4 G; w2 ]- b w9 I) L
1.Promotion of direct reprogramming by transformation-deficient Myc.$ d. e W$ O, @3 D, g
Nakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S.- }2 m' T' ^* V
$ Z; k; j9 B5 i- Z) o! u* A
Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp
/ w9 E8 `7 h' {3 l$ P. ]! |http://www.ncbi.nlm.nih.gov/pubmed/20660764
4 H k) f& T- [; I) b) j/ D
- P$ T7 E; p: `0 [# n( @2.Stem Cells. 2010 Aug;28(8):1349-54.; V# @( r8 N* p/ I! T2 |0 k7 `# ~
Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.$ {/ |3 J" V6 J3 @
Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A.4 W7 D( K6 Y+ P1 j
& c' o+ b. N% _! \Departments of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.# U% {6 t H2 e( K2 z! K
http://www.ncbi.nlm.nih.gov/pubmed/20572015
1 g9 b* p1 Z ?, x6 U6 k2 W8 v3 u( M$ b
3.Nat Biotechnol. 2010 May;28(5):521-6. Epub 2010 May 2.: v8 @1 R& e* N
Dynamic single-cell imaging of direct reprogramming reveals an early specifying event.
, [( q+ t4 C4 L' H" f8 cSmith ZD, Nachman I, Regev A, Meissner A.
2 c2 H# |" n0 W, {& F0 L
+ _2 Z k8 u! g% y2 xBroad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.0 Z- O" S( a" v+ E. `4 c
Comment in:. c2 P6 A( L( R
3 k1 i8 \2 }: ^- J' GRegen Med. 2010 Jul;5(4):501-3.
% _8 o( |5 m: C. ]# g/ V' g1 A# lhttp://www.ncbi.nlm.nih.gov/pubmed/20436460
, ~- i3 w& D/ I, I& p, c- n8 i6 V7 @
4.PLoS One. 2010 Mar 24;5(3):e9838.1 Z5 p9 k- ]* ?( o9 c, ?" G
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.
% ?9 D( N( j5 P# j- B; E0 fChang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.
v% L; F( u1 F2 |% W1 V4 `" l; B9 ^5 t1 {& U# S) M( _
Molecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America./ p* j- T3 i1 Q& F( b; k. a
http://www.ncbi.nlm.nih.gov/pubmed/20352099
* l9 V* J. j2 S* c8 r+ S; {. O( A) f7 D f1 p: u9 A
5.Dev Growth Differ. 2010 Apr;52(3):319-33. Epub 2010 Mar 7.8 T o; V) y9 O! H/ h* H9 r$ P
Direct reprogramming 101.- P+ k! @! A" H
Takahashi K.
" p3 L8 }* p. N
( E# m' N2 o2 `9 m" XCenter for iPS cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan. takahash@cira.kyoto-u.ac.jp
* R7 K k5 |: E& G, f; k6 F' ~http://www.ncbi.nlm.nih.gov/pubmed/20298260* l6 P/ N! T! A; z( K
1 ?. k u9 N h' G% Z# M# @# D6.Nature. 2009 Oct 1;461(7264):649-3.
5 h$ S9 v% Q" Q8 mDirect reprogramming of human neural stem cells by OCT4.
# i3 J/ B, M6 {5 NKim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.
) O1 D7 \& ^2 J& @ n* G- V
& Q5 V c+ t% u8 G& n+ KMax Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology, Röntgenstrasse 20, 48149 Münster, NRW, Germany. d* J/ R7 C& N7 z- O: {5 l3 s" N- Z
http://www.ncbi.nlm.nih.gov/pubmed/19718018
2 j$ H' U) H, d. i* i) ]4 @9 Y: K7 V. A# _( [
7.Blood. 2009 Aug 27;114(9):1764-7. Epub 2009 Jun 29.
4 p {4 M2 a% s' T2 [Definitive proof for direct reprogramming of hematopoietic cells to pluripotency., Z c' _& Z2 M) V; |
Okabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H.
7 R: v$ t: f/ }, Z
7 X, @) C, H' J1 [Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.% K" S1 A* x4 W, A2 S
http://www.ncbi.nlm.nih.gov/pubmed/19564635 [% o M; y+ N! X$ v, {
d4 j% J8 U/ F1 A6 [. f3 @8.Cell Biol Int. 2009 Dec;33(12):1268-73. Epub 2009 Jun 12.
y( P/ w- O9 P$ P1 v- y8 dRole of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
7 u( V6 ]. E; g. M) uChen M, Sun X, Jiang R, Shen W, Zhong X, Liu B, Qi Y, Huang B, Xiang AP, Ge J.
6 E1 {. w, h8 q7 @) B
% S4 N1 g' S- w7 y0 U! pState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
3 g% T c- S$ \* \& Z+ f3 [" Lhttp://www.ncbi.nlm.nih.gov/pubmed/19524692. g6 p3 w p8 G8 `& {6 f& V
# T9 u8 C- l4 @' Y9.Mol Ther. 2009 Jun;17(6):947-53. Epub 2009 Mar 31.
H. |. @3 L- c2 h1 ?6 bUpping the ante: recent advances in direct reprogramming.$ ?* k' K2 v" _0 k% S5 {+ K) t! V
Müller LU, Daley GQ, Williams DA.
, @; |( d r( A. r5 p
! i. k- `7 H3 `8 h0 b& }0 YDepartment of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.7 A$ i6 Z* {2 U# m+ Y
Comment in:
* R" E+ A9 q2 y! K! u+ Z- ?& j, T' q8 F& F8 I" R
Mol Ther. 2009 Jun;17(6):929-30.: E" w9 z* @; u2 a9 t, z
http://www.ncbi.nlm.nih.gov/pubmed/193372339 I/ R) J) r- r2 X( k
4 ?4 }% p4 I: m2 ~10.Cell Stem Cell. 2008 Sep 11;3(3):346-53.3 ]9 h+ n" c$ T" L1 ~5 m
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.; h: R- l7 D- B9 ]9 ~) h2 {- f
Hockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R.2 h; E/ h$ @0 M% s/ q0 y1 x
/ s v3 r/ F+ c) P7 LThe Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.
" q7 v1 e) [% L+ j* a0 C# Ghttp://www.ncbi.nlm.nih.gov/pubmed/18786421 i; G4 I( |& m
~: d# u2 D' p* P5 e7 l11.Nat Biotechnol. 2008 Aug;26(8):916-24. Epub 2008 Jul 1.1 A& K4 y. s1 s$ A2 ]
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types./ X ^/ c4 q0 r$ v& J, x
Wernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R.# C- A, n* C q) b( F/ K
/ I& c7 Z I6 @" H. fWhitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.# ?. R1 d# ?1 R5 L* g7 i* u
http://www.ncbi.nlm.nih.gov/pubmed/18594521, [3 p$ f% J3 d. e- o/ Q
6 I2 B: A3 i8 H; \
12.Nature. 2008 Jul 3;454(7200):49-55. Epub 2008 May 28.0 d# r1 I: a! D- N0 D
Dissecting direct reprogramming through integrative genomic analysis.
1 J. |0 J% _6 e! b. r: RMikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A.. C# \+ F" @- t1 s
% X* \1 w: a" {) E: e' g8 K
Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
0 p5 ~+ A! p7 \$ D1 Jhttp://www.ncbi.nlm.nih.gov/pubmed/18509334
. g' c! ^/ {: f: u3 X6 a; L0 B9 N6 G2 ?7 F- J
13.Cell. 2008 Apr 18;133(2):250-64.
& |% f! j+ n* z/ FDirect reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
) L# e# t, M% U# K3 O! dHanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.4 y* P6 D, Y n- F$ s
; n: X9 ^! n6 W0 h) ]" ]The Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
- n$ H3 U( t6 R6 r! t, x1 y: }http://www.ncbi.nlm.nih.gov/pubmed/184231978 L4 W( |# T$ f; j2 b. h$ ~
4 H" }* h( r. e* W; _% x+ t14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.( V) h! \9 m" i0 q" r2 p& Q9 H9 D
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
c2 t( m6 v- G; d6 wBrambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R.8 S8 w" Q( n' P' H/ Q' @' o+ ^
% C" ~8 _6 {8 N* `0 Z4 q e, uWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.
7 V; W p, o: ^7 Y$ C0 A! Whttp://www.ncbi.nlm.nih.gov/pubmed/18371436
. R9 ~2 W: M8 ]( q3 ]
3 m: o5 c( _5 m: Z4 i! |1 ?15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13.
6 v' d7 I, ~0 _4 rc-Myc is dispensable for direct reprogramming of mouse fibroblasts.
5 J! M, D" \4 V; ~Wernig M, Meissner A, Cassady JP, Jaenisch R.
7 r1 `3 ^: M! `3 t" ehttp://www.ncbi.nlm.nih.gov/pubmed/18371415
" X. T: F: m# k: L+ U: |
, {. k: @* e( U2 S0 W3 }16.Cell Stem Cell. 2007 Dec 13;1(6):593-4.$ I) o# D, U9 R' o( r7 X
The first direct reprogramming of adult human fibroblasts.
! M' R9 Y7 o: \3 A! @Wilmut I.) B2 {9 B2 ~7 f# D- G$ Y
. U& L6 {0 b9 Y# e& o; |* q. k1 _Scottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. ian.wilmut@ed.ac.uk. t1 Y# J" R& }; s5 `
http://www.ncbi.nlm.nih.gov/pubmed/18371396
6 D; {' r0 P% {1 _! x' J; J
6 Y' I9 d" K* r S, I' Z. n17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.4 W Y3 d3 g$ X- a1 `# P
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.' @) i9 V' S! B6 i
Meissner A, Wernig M, Jaenisch R.
4 q# W9 [8 L; q) @5 D- H# Q
& S+ X* q6 Q8 q( y _% g, G$ ZWhitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Nine Cambridge Center, Cambridge Massachusetts 02142, USA.0 e1 O, {. a/ Z3 a$ ^; w
http://www.ncbi.nlm.nih.gov/pubmed/17724450 |
|